SN1 N Stock Overview
Develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 2/6 |
| Past Performance | 3/6 |
| Financial Health | 4/6 |
| Dividends | 5/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Smith & Nephew plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£256.55 |
| 52 Week High | UK£290.15 |
| 52 Week Low | UK£215.59 |
| Beta | 0.62 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -41.76% |
Recent News & Updates
Recent updates
Shareholder Returns
| SN1 N | MX Medical Equipment | MX Market | |
|---|---|---|---|
| 7D | 0% | 0% | 0% |
| 1Y | n/a | 0% | 0% |
Return vs Industry: Insufficient data to determine how SN1 N performed against the MX Medical Equipment industry.
Return vs Market: Insufficient data to determine how SN1 N performed against the MX Market.
Price Volatility
| SN1 N volatility | |
|---|---|
| SN1 N Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 0% |
| Market Average Movement | 0% |
| 10% most volatile stocks in MX Market | 0% |
| 10% least volatile stocks in MX Market | 0% |
Stable Share Price: SN1 N's share price has been volatile over the past 3 months compared to the MX market.
Volatility Over Time: Insufficient data to determine SN1 N's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1856 | 17,349 | Deepak Nath | www.smith-nephew.com |
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. It operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.
Smith & Nephew plc Fundamentals Summary
| SN1 N fundamental statistics | |
|---|---|
| Market cap | Mex$245.11b |
| Earnings (TTM) | Mex$8.10b |
| Revenue (TTM) | Mex$114.26b |
30.3x
P/E Ratio2.1x
P/S RatioIs SN1 N overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SN1 N income statement (TTM) | |
|---|---|
| Revenue | US$5.81b |
| Cost of Revenue | US$1.73b |
| Gross Profit | US$4.08b |
| Other Expenses | US$3.67b |
| Earnings | US$412.00m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
Jul 31, 2025
| Earnings per share (EPS) | 0.47 |
| Gross Margin | 70.21% |
| Net Profit Margin | 7.09% |
| Debt/Equity Ratio | 59.4% |
How did SN1 N perform over the long term?
See historical performance and comparisonDividends
2.6%
Current Dividend Yield79%
Payout RatioDoes SN1 N pay a reliable dividends?
See SN1 N dividend history and benchmarks| Smith & Nephew dividend dates | |
|---|---|
| Ex Dividend Date | Mar 27 2025 |
| Dividend Pay Date | May 28 2025 |
| Days until Ex dividend | 52 days |
| Days until Dividend pay date | 10 days |
Does SN1 N pay a reliable dividends?
See SN1 N dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/07 09:12 |
| End of Day Share Price | 2025/02/07 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Smith & Nephew plc is covered by 53 analysts. 18 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Christoph Gubler | Bank Vontobel AG |
| Sally Taylor | Barclays |
| Hassan Al-Wakeel | Barclays |